HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

338.817

-3.840-1.12%

Number of Gainers:13

Number of Losers:26

Number of Flat:20

PE:- -

High:342.639

Open:342.639

Low:337.515

Close:342.657

Volume:31.50M

Turnover:861.75M

Market Cap:805.45B

Float Cap:699.92B

Loading ...

Mixue Likely to Face Headwinds

Mixue Shares Extend Slide After Profit Decline

CLSA Reaffirms Outperform on Bilibili, Trims Target Price as Ad Growth Stays Strong

Hutchmed (China) Announces NMPA Conditional Approval for ATLED in China

HUTCHMED's Cholangiocarcinoma Drug Application Gets Conditional Nod in China

MT Newswires Live

Hutchmed (China) - Fanregratinib to be Marketed in China as Atled

THOMSON REUTERS

Morimatsu International Holdings (SEHK:2155) Reports A Half Year Loss, Is The Stock Cheap?

Simply Wall St.

New Hope Service Reports Interim Results with 17% Profit Dip

China's New Hope Service H1 Profit Falls 17%

New Hope Service - ‍Interim Dividend of Hk$0.096 Per Share

THOMSON REUTERS

New Hope Service Holdings H1 Revenue RMB 771.1 Million

THOMSON REUTERS

New Hope Service FY26 Interim Profit Attributable to Shareholders Falls 17% to RMB 100.4 Million; Revenue Rises 4.2% to RMB 771.1 Million

Bilibili Hong Kong Shares Climb Most in 4 Weeks on Q2 Profit Growth

CMB International Cuts Li Auto-W Price Target to HK$47, Maintains 'Hold' Rating

Hong Kong Market Movers: Mixue's Revenue Reaches RMB 15.2 Billion in First Half, Global Store Network Expands

HUTCHMED secures NMPA approval for ATLED to address FGFR2-altered intrahepatic cholangiocarcinoma

Hutchmed (China) - Announces Nmpa Conditional Approval for Atled (Fantegratinib) in China

THOMSON REUTERS

Hutchmed Says China NMPA Approves ATLED for FGFR2-Altered Intrahepatic Cholangiocarcinoma

Hutchmed Announces Nmpa Approval for Atled® (Fanregratinib) for the Treatment of Patients with Fgfr2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

THOMSON REUTERS

Chinese Education Co Fenbi's H1 Revenue Falls, Posts Net Loss

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK1587/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1587","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","market":"HK","secType":"PLATE","nameCN":"Sub-New Stocks","latestPrice":338.81714,"timestamp":1788229037753,"preClose":342.6574,"halted":0,"volume":31502253,"delay":0,"changeRate":-0.011207,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-3.840271,"latestTime":"09-01 10:17:18","open":342.63876,"high":342.63876,"low":337.51508,"amount":861746982,"amplitude":0.014953,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788235200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"pbRate":1.433284,"peRate":16.066997,"turnoverRate":0.000663,"increases":13,"decrements":26,"flats":19,"marketCap":805454935848,"floatMarketCap":699922632884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","high":342.63876,"amplitude":0.014953,"preClose":342.6574,"low":337.51508,"pbRate":"1.433284","latestPrice":338.81714,"volume":31502253,"delay":0,"open":342.63876,"prevYearClose":478.5753,"prevWeekClose":340.909,"prevMonthClose":342.657,"prevQuarterClose":326.657,"fiveDayClose":344.793,"twentyDayClose":365.97,"sixtyDayClose":380.499,"secType":"PLATE","market":"HK","turnoverRate":0.000663,"peRate":16.066997,"marketCap":805454935848,"floatMarketCap":699922632884,"timestamp":1788229037753,"nameCN":"Sub-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1587\",,,,undefined,":{"bkCode":"BK1587","up":13,"down":26,"flat":20},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1587\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662057525","title":"Mixue Likely to Face Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2662057525","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662057525?lang=en_us&edition=fundamental","pubTime":"2026-08-28 15:56","pubTimestamp":1787903760,"startTime":"0","endTime":"0","summary":"0756 GMT - Mixue is expected to face headwinds in the near term, according to Deutsche Bank's Han Zhang. The analyst says the Chinese food-and-beverage chain's 1H miss \"revealed short-term weakness amid strategy execution,\" noting the drag from average sales per store. \"Contributions from ingredient upgrades and the coffee business rollout still take a long time to bear fruit, which presents downside risk to margins in the near term,\" the analyst adds in a note. Mixue is also facing intensified industry competition, as peers are expanding operations into both the tea and coffee businesses, Deutsche Bank notes. It keeps a buy rating on the stock but cuts the target price to HK$203.00 from HK$240.60. Shares fall 6.3% to HK$213.40.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1233","02097","BK1616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662057569","title":"Mixue Shares Extend Slide After Profit Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2662057569","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662057569?lang=en_us&edition=fundamental","pubTime":"2026-08-28 15:53","pubTimestamp":1787903580,"startTime":"0","endTime":"0","summary":"Mixue Group shares continued to fall Friday, extending losses for a second consecutive session, after the Chinese fast-food chain said rising costs took a bite out of first-half profit.The stock fell ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Mixue Shares Extend Slide After Profit Decline","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1233","02097","BK1616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161691981","title":"CLSA Reaffirms Outperform on Bilibili, Trims Target Price as Ad Growth Stays Strong","url":"https://stock-news.laohu8.com/highlight/detail?id=1161691981","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161691981?lang=en_us&edition=fundamental","pubTime":"2026-08-28 15:11","pubTimestamp":1787901115,"startTime":"0","endTime":"0","summary":"CLSA has released a research report reaffirming its \"Outperform\" rating on BILIBILI-W (09626), while trimming its adjusted net profit forecasts for 2026 and 2027 by 5% and 8%, respectively. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","BK1104","BK1615","BK4509","SG9999001093.SGD","BK1608","SG9999003461.SGD","BK1587","BK4588","BK4577","BK4505","LU2097828474.EUR","SG9999001051.SGD","LU2097828714.EUR","BK4503","LU2097828631.EUR","BK1588","BK1095","BK4554","BK1618","LU2097828805.USD","BK4510","BK4566","BK4585","SG9999001069.SGD","BK4526","09626","SG9999006597.SGD","BK4548","BILI","BK4085","BK4531","BK1575","BK4504","BK4077","BK4563","IE0034224299.USD","BK4513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662105129","title":"Hutchmed (China) Announces NMPA Conditional Approval for ATLED in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662105129","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662105129?lang=en_us&edition=fundamental","pubTime":"2026-08-28 14:33","pubTimestamp":1787898839,"startTime":"0","endTime":"0","summary":"Aug 28 (Reuters) - HUTCHMED (China) Ltd <0013.HK>::*HUTCHMED CHINA LTD  - NMPA APPROVAL FOR ATLED (FANREGRATINIB) FOR ICC*HUTCHMED (CHINA) - ANNOUNCES NMPA CONDITIONAL APPROVAL FOR FANREGRATINIB (ATLE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nRSD3GHcnc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1587","00013","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662051234","title":"HUTCHMED's Cholangiocarcinoma Drug Application Gets Conditional Nod in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662051234","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662051234?lang=en_us&edition=fundamental","pubTime":"2026-08-28 14:31","pubTimestamp":1787898702,"startTime":"0","endTime":"0","summary":"HUTCHMED (China)'s (HKG:0013) new drug application for fanregratinib (HMPL-453) was conditionally approved by China's National Medical Products Administration.The approval is for the treatment of adul","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ18W340.USD","LU1282649810.SGD","00013","BK1588","LU0488056044.USD","IE00BZ18W456.USD","LU1282649067.USD","IE00BMQBXF63.USD","LU0414403682.SGD","BK1191","BK1185","00177","BK1587","LU0738912210.USD","LU1211504680.USD","SG9999002950.SGD","LU0384037296.USD","BK1567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662505925","title":"Hutchmed (China) - Fanregratinib to be Marketed in China as Atled","url":"https://stock-news.laohu8.com/highlight/detail?id=2662505925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662505925?lang=en_us&edition=fundamental","pubTime":"2026-08-28 14:00","pubTimestamp":1787896806,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUC4PNLXG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1191","BK1588","00013"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068853","title":"Morimatsu International Holdings (SEHK:2155) Reports A Half Year Loss, Is The Stock Cheap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068853","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662068853?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:45","pubTimestamp":1787892303,"startTime":"0","endTime":"0","summary":"Morimatsu International Holdings (SEHK:2155) is in focus after reporting unaudited half year results to June 30, 2026. The company moved from net income to a net loss, with lower sales and weaker per share metrics.\nThe earnings release appears to have coincided with a sharp shift in sentiment, with Morimatsu International Holdings’ share price rising 7.03% on the day and delivering a 16.81% 1 month share price return. However, momentum has faded compared to the 13.90% 3 month share price...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3072000-choice1-main-header/1585186775716","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3072000-choice1-main-header/1585186775716"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/capital-goods/hkg-2155/morimatsu-international-holdings-shares/news/morimatsu-international-holdings-sehk2155-reports-a-half-yea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/capital-goods/hkg-2155/morimatsu-international-holdings-shares/news/morimatsu-international-holdings-sehk2155-reports-a-half-yea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2279858448.HKD","02155","BK1183","DCF","BK1587","BK1548","LU1171460220.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125974711","title":"New Hope Service Reports Interim Results with 17% Profit Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=1125974711","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125974711?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:22","pubTimestamp":1787890952,"startTime":"0","endTime":"0","summary":"New Hope Service (03658) has announced its interim results for the six months ended June 30, 2026. The group recorded revenue of RMB 771 million, reflecting a year-on-year increase of 4.23%. However,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","03658","BK1229","BK1542","BK1258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055610","title":"China's New Hope Service H1 Profit Falls 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055610","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055610?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:16","pubTimestamp":1787890569,"startTime":"0","endTime":"0","summary":"China's New Hope Service H1 profit falls 17%OverviewChina property management firm's H1 revenue rose 4.2% yr/yr to RMB771.1 mlnNet profit attributable to shareholders fell 17% yr/yr to RMB100.4 mlnCom","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P045:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK0015","600048","BK1555","LU1720050803.USD","LU1224709979.USD","LU0082770016.USD","03658","LU1997245094.SGD","BK0082","BK0273","BK0010","LU1794554557.SGD","BK0028","BK0196","BK1258","BK0012","BK1542","BK1240","LU1997245177.USD","BK1587","BK1229","LU0348767384.USD","BK0189","LU2279858448.HKD","LU0348766576.USD","BK0188","BK1589","LU0287142896.SGD","BK0183","LU1171460220.USD","01238","BK0187","LU0173614495.USD","06049","LU0737861699.HKD","09909"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662905580","title":"New Hope Service - ‍Interim Dividend of Hk$0.096 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662905580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662905580?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:06","pubTimestamp":1787889974,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nPLX116T32:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1229","BK1258","03658","BK1587","BK1542"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055804","title":"New Hope Service Holdings H1 Revenue RMB 771.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055804?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:06","pubTimestamp":1787889974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nPLX116T32:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1542","BK1587","BK1258","03658","BK1229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055870","title":"New Hope Service FY26 Interim Profit Attributable to Shareholders Falls 17% to RMB 100.4 Million; Revenue Rises 4.2% to RMB 771.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055870","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055870?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:05","pubTimestamp":1787889942,"startTime":"0","endTime":"0","summary":"New Hope Service FY26 interim profit attributable to shareholders falls 17% to RMB 100.4 million; revenue rises 4.2% to RMB 771.1 millionNew Hope Service posted revenue of RMB 771.1 million, up 4.2%, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL2lr0jz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03658","BK1258","BK1587","BK1229","BK1542"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603053","title":"Bilibili Hong Kong Shares Climb Most in 4 Weeks on Q2 Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603053","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662603053?lang=en_us&edition=fundamental","pubTime":"2026-08-28 11:36","pubTimestamp":1787888160,"startTime":"0","endTime":"0","summary":"BUZZ-Bilibili Hong Kong shares climb most in 4 weeks on Q2 profit growth** Hong Kong shares of Bilibili9626.HKclimb 4.3% to HK$135.3, on course for the biggest one-day pct gain since July 29** Stock t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P03C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034224299.USD","BK1615","LU2097828805.USD","SG9999003461.SGD","09626","BK1587","BK1618","LU2097828631.EUR","SG9999001051.SGD","SG9999001069.SGD","BK1575","BK1104","BILI","SG9999001093.SGD","LU2097828474.EUR","BK1608","BK1588","SG9999006597.SGD","LU2097828557.USD","BK1095","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153633988","title":"CMB International Cuts Li Auto-W Price Target to HK$47, Maintains 'Hold' Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1153633988","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153633988?lang=en_us&edition=fundamental","pubTime":"2026-08-28 11:14","pubTimestamp":1787886897,"startTime":"0","endTime":"0","summary":"CMB International has released a research report indicating that Li Auto-W (02015) delivered second-quarter results broadly in line with expectations. However, the company's third-quarter guidance...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02015","IDRV","LU1794554557.SGD","BK1587","LU1720050803.USD","BK1588","BK1575","LI","BK1539","BK1119"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108068616","title":"Hong Kong Market Movers: Mixue's Revenue Reaches RMB 15.2 Billion in First Half, Global Store Network Expands","url":"https://stock-news.laohu8.com/highlight/detail?id=1108068616","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108068616?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:12","pubTimestamp":1787879553,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) has received approval from China's National Medical Products Administration for Elenestinib (futibatinib) to treat patients with FGFR2 fusion/rearrangement intrahepatic...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","BK1233","HK0000252152.HKD","LU2460026573.USD","BK1161","BK1219","02005","02097","BK1191","LU2543165471.USD","BK4585","VXUS","09606","00013","KCAI","HK0000252160.HKD","BK1588","BK1587","BK4588","BK1616","02273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173033221","title":"HUTCHMED secures NMPA approval for ATLED to address FGFR2-altered intrahepatic cholangiocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1173033221","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173033221?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:20","pubTimestamp":1787876419,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) has announced that its New Drug Application for fanregratinib (HMPL-453) has received conditional approval from China's National Medical Products Administration (NMPA). The approval...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00013","BK1588","BK1587","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662343060","title":"Hutchmed (China) - Announces Nmpa Conditional Approval for Atled (Fantegratinib) in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662343060","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662343060?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:00","pubTimestamp":1787875259,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44O1JE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00013","BK1588","BK1587","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662303435","title":"Hutchmed Says China NMPA Approves ATLED for FGFR2-Altered Intrahepatic Cholangiocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2662303435","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662303435?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:00","pubTimestamp":1787875220,"startTime":"0","endTime":"0","summary":"HUTCHMED says China NMPA approves ATLED for FGFR2-altered intrahepatic cholangiocarcinomaChina’s NMPA granted conditional clearance for ATLED (fanregratinib) to treat FGFR2 fusion/rearrangement intrah","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL2hfQ31:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","BK4585","SG9999014039.USD","SG9999014005.SGD","LU2095319765.USD","BK4588","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","BK1587","NDAQ","LU2210150020.SGD","BK1588","LU2210149790.SGD","LU0314104364.USD","IE00BQXX3F31.USD","00013","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","BCDF","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","BK1191","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662034389","title":"Hutchmed Announces Nmpa Approval for Atled® (Fanregratinib) for the Treatment of Patients with Fgfr2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2662034389","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662034389?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:00","pubTimestamp":1787875200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUA8W8TRJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1588","00013","BK1587","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662083911","title":"Chinese Education Co Fenbi's H1 Revenue Falls, Posts Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2662083911","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662083911?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:48","pubTimestamp":1787838495,"startTime":"0","endTime":"0","summary":"Chinese education co Fenbi's H1 revenue falls, posts net lossOverviewChina online education provider's H1 revenue fell 16% yr/yrCompany posted net loss for H1, compared to profit a year earlierAverage","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02469","BK4506","BK4510","BK4531","06913","BK4503","01569","BK1228","BK1556","GOTU","BK4204","BK4552"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":6,"totalSize":307,"code":"91000000","status":"200"}]}}